Belustine (Lomustine) 40 mg Capsule is an oral chemotherapy medicine that treats brain tumors, Hodgkin’s lymphoma, and certain lung cancers. It belongs to the group of alkylating agents and works by slowing the growth of cancer cells. For detailed clinical guidance, check Mayo Clinic and Drugs.com.

Key Benefits & Uses

• Helps manage primary and metastatic brain tumors effectively

• Supports treatment of Hodgkin’s lymphoma when combined with other medicines

• Offers benefits in certain lung and rare cancers

• Medical research at PubMed confirms its effectiveness

How to Use

Take Belustine orally with water, usually as a single dose once every 6 weeks or exactly as your oncologist prescribes. Do not crush or chew the capsule. Since food may delay absorption, follow your doctor’s specific directions carefully. To understand approved guidelines, visit the FDA.

Important Safety Information

• Doctors usually recommend regular blood tests to track bone marrow health

• Avoid live vaccines during therapy (see WHO)

• Always inform your doctor about liver, kidney, or lung issues before treatment

• Women should avoid pregnancy during therapy, as Belustine may harm the unborn child

Common Side Effects

• Nausea, vomiting, and appetite loss often appear in the first days

• Low blood cell count increases the risk of infection, bleeding, and fatigue

• Some patients may experience mouth sores, diarrhea, or lung-related complications
  For a full list of side effects, refer to WebMD and Healthline.

Why Choose Belustine?

Doctors recommend Belustine for its proven success in difficult-to-treat cancers. Clinical studies and real-world evidence highlight its role in improving outcomes. In addition, it remains a trusted option backed by oncologists worldwide. For further insights, explore Mayo Clinic and PubMed.